Company intelligence / Profile preview

IVDiagnostics

Valparaiso, Indiana, United Statesivdiagnostics.com ↗

Ownership: Private
Development stage: Commercial

Overview

IVDiagnostics was known for developing advanced diagnostic platforms aimed at detecting circulating tumor cells in blood samples, with the goal of enabling earlier cancer diagnosis and improved patient monitoring. The company’s technology was designed to offer high sensitivity for rare cell detection but there is no recent public data on clinical results or commercial adoption.

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic assayMolecular diagnostics
Industry: Molecular Diagnostics

Drug pipeline

1 asset

CTC capture test

Commercial

Indications: Breast cancer, Prostate cancer, Colorectal cancer

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed in recent years.

Beyond the preview

Go deeper on IVDiagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IVDiagnostics.

Explore the full profile